David P. Ryan

34.7k citations
327 papers · 27.5k · 13 hit papers · h-index 80

Impact in

  • Oncology top 0.05%
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Surgical Treatments
    • Colorectal Cancer Treatments and Studies
  • Hepatology top 0.5%
    • Hepatocellular Carcinoma Treatment and Prognosis

Papers in

    • Pancreatic and Hepatic Oncology Research 73
    • Colorectal Cancer Treatments and Studies 47
    • Colorectal Cancer Surgical Treatments 31
    • Hepatocellular Carcinoma Treatment and Prognosis 18

David P. Ryan

317 papers receiving 26.7k citations

David P. Ryan's Hit Papers

Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial 2023 · 152 citations
1520+7+14Years since publication5001k1.5k

Peers

David P. Ryan
Comparison fields: 5 of 162
  • Oncology 11.8k
  • Hepatology 1.4k
  • Cancer Research 2.1k
  • Pulmonary and Respiratory Medicine 2.3k
  • Surgery 2.7k
Replace Eileen Mary O'Reilly with:
Eileen Mary O'Reilly United States
Robert A. Wolff United States
Jeffrey William Clark United States
Carol Rossier Bradford United States
Deepa Naishadham United States
Joseph M. Herman United States
Andrès M.R. Cervantes Spain
Christopher Lee Wolfgang United States
Jonathan A. Ledermann United Kingdom
Nicholas James Petrelli United States
David P. Ryan relative to Eileen Mary O'Reilly United States Eileen Mary O'Reilly's profile →
Citations per field
00.5×1.5×1.9×
Eileen Mary O'Reilly · 1×
Citations per year

Countries citing papers authored by David P. Ryan

Since Specialization
Citations

This map shows the geographic impact of David P. Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David P. Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David P. Ryan more than expected).

Fields of papers citing papers by David P. Ryan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David P. Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David P. Ryan. The network helps show where David P. Ryan may publish in the future.

Co-authors

The 25 scholars most cited alongside David P. Ryan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David P. Ryan Line = papers co-authored together David P. Ryan links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 327 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Pancreatic Adenocarcinoma
Hit paper breakdown →
20141838
2
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer
Hit paper breakdown →
20041655
3
Radiological and Surgical Implications of Neoadjuvant Treatment With FOLFIRINOX for Locally Advanced and Borderline Resectable Pancreatic Cancer
Hit paper breakdown →
2014684
4
Effects of Early Integrated Palliative Care in Patients With Lung and GI Cancer: A Randomized Clinical Trial
Hit paper breakdown →
2017657
5
Frequent Mutation of Isocitrate Dehydrogenase(IDH)1andIDH2in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
Hit paper breakdown →
2011637
6 2009593
7
Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
Hit paper breakdown →
2008509
8
Polyclonal Secondary FGFR2 Mutations Drive Acquired Resistance to FGFR Inhibition in Patients with FGFR2 Fusion–Positive Cholangiocarcinoma
Hit paper breakdown →
2016468
9
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer
Hit paper breakdown →
2019450
10 2018442
11 2015441
12 2006425
13 2012420
14
Liquid versus tissue biopsy for detecting acquired resistance and tumor heterogeneity in gastrointestinal cancers
Hit paper breakdown →
2019409
15 2009392
16 2009391
17 2000366
18 2012358
19
Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma
Hit paper breakdown →
2015358
20 2005357

About David P. Ryan

David P. Ryan is a scholar working on Oncology, Hepatology, Surgery, Pulmonary and Respiratory Medicine and Cancer Research, having authored 327 papers that have together received 27.5k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (73 papers), Colorectal Cancer Treatments and Studies (47 papers), Colorectal Cancer Surgical Treatments (31 papers), Hepatocellular Carcinoma Treatment and Prognosis (18 papers), Colorectal and Anal Carcinomas (16 papers), Neuroendocrine Tumor Research Advances (13 papers), Cancer Genomics and Diagnostics (12 papers) and Gastric Cancer Management and Outcomes (11 papers). The work is most often cited by research in Oncology (11.8k citations), Hepatology (1.4k citations), Cancer Research (2.1k citations), Pulmonary and Respiratory Medicine (2.3k citations) and Surgery (2.7k citations). David P. Ryan has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Theodore Sunki Hong, Nabeel M. Bardeesy, Jeffrey William Clark, Charles S. Fuchs, Lawrence Scott Blaszkowsky, Andrew Xiuxuan Zhu, Matthew H. Kulke, Peter C. Enzinger, Eunice Lee Kwak and Robert James Mayer. Their work appears in journals such as The Oncologist, Journal of Clinical Oncology, Clinical Cancer Research, Cancer and International Journal of Radiation Oncology*Biology*Physics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact